JAFRON BIOMEDICAL CO.,LTD. Jafron Biomedical Co.,Ltd. Share Price
Equities
300529
CNE100002995
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.15 CNY | +12.23% |
|
+18.01% | +17.63% |
| 04-26 | Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023 | CI |
| 04-25 | Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2024 * | 2.52B 347M 27.81B | Sales 2025 * | 2.99B 412M 33.02B | Capitalization | 20.25B 2.79B 224B |
|---|---|---|---|---|---|
| Net income 2024 * | 775M 107M 8.57B | Net income 2025 * | 940M 130M 10.39B | EV / Sales 2024 * | 8.05 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 6.78 x |
| P/E ratio 2024 * |
27.3
x | P/E ratio 2025 * |
22.4
x | Employees | 3,003 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.08% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +12.23% | ||
| 1 week | +18.01% | ||
| Current month | +17.63% | ||
| 1 month | +16.43% | ||
| 3 months | +40.37% | ||
| 6 months | +28.44% | ||
| Current year | +17.63% |
1 week
22.02
26.47
1 month
21.7526.47
Current year
15.8826.47
1 year
15.8829.67
3 years
15.88103.00
5 years
15.88103.00
10 years
6.82103.00
| Managers | Title | Age | Since |
|---|---|---|---|
Fan Dong
CEO | Chief Executive Officer | 54 | 31/12/98 |
Yao Hong Chen
BRD | Director/Board Member | 45 | 31/12/12 |
Feng Li
BRD | Director/Board Member | 54 | 31/12/09 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Guo Qing Guo
BRD | Director/Board Member | 62 | 20/04/23 |
Yan Jun Xu
BRD | Director/Board Member | 51 | 20/04/23 |
Fan Dong
CEO | Chief Executive Officer | 54 | 31/12/98 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.44% | 2 M€ | -16.59% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 26.15 | +12.23% | 32,811,610 |
| 25/04/24 | 23.3 | +1.84% | 6,539,200 |
| 24/04/24 | 22.88 | +1.33% | 4,735,290 |
| 23/04/24 | 22.58 | -0.96% | 6,658,643 |
| 22/04/24 | 22.8 | +2.89% | 7,707,108 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Companyâs products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Companyâs products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Companyâs products are applied in 31 provinces, more than 3000 hospitals in China.
Calendar
20/05/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
26.15
CNY
Average target price
26.62
CNY
Spread / Average Target
+1.78%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +17.63% | 2.88B | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- 300529 Stock
